An act to add Chapter 1.5 (commencing with Section 24200) to Division 20 of the Health and Safety Code, relating to gene synthesis.
Impact
The bill strengthens existing laws related to gene synthesis and requires adherence to a regulatory framework designed to ensure safety and mitigate risks associated with synthetic nucleic acids. By implementing compliance standards, the bill aims to prevent reckless or malicious actions from individuals or companies that could endanger public health. The State Department of Public Health will have the authority to adapt regulations relating to the framework, potentially integrating federal standards that achieve an equal or greater level of protection for Californians.
Summary
Assembly Bill 1864, introduced by Assembly Member Berman, aims to regulate the manufacture and provision of benchtop nucleic acid synthesis equipment in California. The bill mandates that manufacturers must comply with a specific framework known as the Framework for Nucleic Acid Synthesis Screening, as revised in September 2024, before producing or selling these products in the state. This legislation is rooted in the state's commitment to protecting its residents from potential biohazards arising from the misuse of synthetic nucleic acids, which could lead to dangerous biological risks.
Contention
While the bill is intended to enhance safety measures, it may face scrutiny from manufacturers regarding the feasibility of compliance with such stringent regulations. Critics may argue that the increased regulatory environment could inhibit innovation in the biotechnology sector. The potential civil penalties for violations, which may reach up to $1,000 per day, could also be seen as a deterrent for manufacturers operating within the state, raising concerns over the balance between regulation and industry growth. Furthermore, the nuances surrounding the definition of the framework may provoke discussions about the appropriateness and sufficiency of the proposed guidelines.
An act to add Article 3 (commencing with Section 109015) to Chapter 15 of Part 3 of Division 104 of the Health and Safety Code, relating to product safety.
An act to add Section 25534.07 to the Health and Safety Code, and to amend Section 7856 of, and to add and repeal Chapter 3 (commencing with Section 7875) of Part 7.5 of Division 5 of, the Labor Code, relating to employment.
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
An act to add Article 7 (commencing with Section 128570) to Chapter 5 of Part 3 of Division 107 of the Health and Safety Code, relating to maternal care and services.
An act to amend Sections 44671 and 49600 of, and to add Chapter 8 (commencing with Section 52210) to Part 28 of Division 4 of Title 2 of, the Education Code, relating to pupil instruction.
A resolution expressing the sense of the Senate that the United States, States, cities, Tribal nations, businesses, institutions of higher education, and other institutions in the United States should work toward achieving the goals of the Paris Agreement.
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
Relating to incentives for the development of the clean hydrogen industry in this state, including tax benefits, loans, and grants for clean hydrogen projects, clean hydrogen workforce development, hydrogen powered motor vehicles, and certain items used to produce clean hydrogen.